Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

49.97
+0.95961.96%
Volume:8.69M
Turnover:430.32M
Market Cap:72.42B
PE:20.25
High:50.04
Open:48.65
Low:48.54
Close:49.01
52wk High:109.50
52wk Low:42.20
Shares:1.45B
Float Shares:1.45B
Volume Ratio:0.49
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):1.94
ROE:15.34%
ROA:6.19%
PB:2.90
PE(LYR):25.76

Loading ...

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Boston Scientific Corp. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Yesterday

Movement Alert|Boston Scientific Falls 3.01% in Regular Trading, Watchman Slowdown and Guidance Cut Continue to Weigh on Shares

Market Focus
·
Yesterday

Should Boston Scientific’s Shift Toward Capital Spending and External Innovation Require Action From (BSX) Investors?

Simply Wall St.
·
Aug 23

Movement Alert|Boston Scientific Rises 3.01% in Regular Trading, Two New Products Approved in China Boosting Market Sentiment

Market Focus
·
Aug 22

Boston Scientific (BSX) Rebounds Sharply, Is The Stock Still A Bargain?

Simply Wall St.
·
Aug 21

Boston Scientific Corp. Stock Slides 5.1%, Underperforms Peers

Dow Jones
·
Aug 21

Movement Alert|Boston Scientific Falls 3.04% in Regular Trading, Guidance Cut and Analyst Downgrades Continue to Weigh on Shares

Market Focus
·
Aug 20

Movement Alert|Boston Scientific Rises 3.21% in Regular Trading, New-Gen Prostate Treatment Device Rezum EVO Approved in China

Market Focus
·
Aug 19

Boston Scientific Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 19

Lone Pine Capital Llc Reports Share Stake of 2.6 Million Shares in Home Depot

Reuters
·
Aug 15

Lone Pine Capital Llc Raises Share Stake in Nu Holdings by 24.2% to 47.2 Mln Class a Shares - SEC Filing

THOMSON REUTERS
·
Aug 15

Lone Pine Capital Llc Dissolves Share Stake in Boston Scientific - SEC Filing

THOMSON REUTERS
·
Aug 15

Movement Alert|Boston Scientific Pre-Market Rise 3.85%, Earnings Beat and Restructuring Plan Continue to Drive Recovery

Market Focus
·
Aug 14

Movement Alert|Boston Scientific Rises 3.29% Overnight, Q2 Earnings Beat and Restructuring Plan Sustain Recovery Momentum

Market Focus
·
Aug 14

Citi Keeps Their Buy Rating on Boston Scientific (BSX)

TIPRANKS
·
Aug 13

Boston Scientific’s MANDARIN Trial Shines Spotlight on Liver Cancer Strategy in China

TIPRANKS
·
Aug 13

Bank of America Securities Reaffirms Their Buy Rating on Boston Scientific (BSX)

TIPRANKS
·
Aug 11

Boston Scientific Corp. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Movement Alert|Boston Scientific Rises 3.01% in Regular Trading, Sector Strength and Post-Earnings Recovery Drive Gains

Market Focus
·
Aug 11